Darapladib Ineffective at Reducing Major Coronary Events after ACS

Article Figures & Data

Figures

  • Figure 1.

    Occurrence of the Primary End Point in the Darapladib and Placebo Treatment Arms

    CHD, coronary heart disease; MI, myocardial infarction.Reproduced with permission from M. O'Donoghue, MD.